FRANKLIN, Tenn.--(BUSINESS WIRE)--Jun. 6, 2018--
Community Health Systems, Inc. (the “Company”) (NYSE:CYH) today
announced that its wholly owned subsidiary, CHS/Community Health
Systems, Inc. (the “Issuer”), has amended certain terms of its
previously commenced offers to exchange (each, an “Exchange Offer” and,
collectively, the “Exchange Offers”) (i) up to $1,925 million aggregate
principal amount of its new Junior-Priority Secured Notes due 2023 (the
“2023 Notes”) in exchange for any and all of its $1,925 million
aggregate principal amount of outstanding 8.000% Senior Unsecured Notes
due 2019 (the “2019 Notes”), (ii) up to $1,200 million aggregate
principal amount of its new 8.125% Junior-Priority Secured Notes due
2024 (the “2024 Notes” and, together with the 2023 Notes, the “New
Notes”) in exchange for any and all of its $1,200 million aggregate
principal amount of outstanding 7.125% Senior Unsecured Notes due 2020
(the “2020 Notes”) and (iii) to the extent that less than all of the
outstanding 2019 Notes and 2020 Notes are tendered in the Exchange
Offers, up to an aggregate principal amount of 2024 Notes equal to, when
taken together with the New Notes issued in exchange for the validly
tendered and accepted 2019 Notes and 2020 Notes, $3,125 million, in
exchange for its outstanding 6.875% Senior Unsecured Notes due 2022 (the
“2022 Notes” and, together with the 2019 Notes and the 2020 Notes, the
“Old Notes”). The maximum aggregate principal amount of New Notes issued
in the Exchange Offers will not exceed $3,125 million (the “Maximum
Exchange Amount”).
The amendments to the Exchange Offers (i) increase the interest rate on
the 2023 Notes by 1.125% per annum, from 9.875% to 11.000% per annum,
solely for the period from the issue date of such 2023 Notes to, but
excluding, the one year anniversary thereof, (ii) modify the negative
covenants that will be applicable to the New Notes to prohibit the
Issuer from purchasing, repurchasing, redeeming, defeasing or otherwise
acquiring or retiring any outstanding 2019 Notes or 2020 Notes after the
consummation of the Exchange Offers with cash or cash equivalents
presently on hand, cash from operations, with proceeds from assets sales
or with proceeds from the issuance of, or in exchange for, secured debt
prior to the date that is 60 days prior to the relevant maturity dates
of such 2019 Notes or 2020 Notes, as applicable, and (iii) extend the
“Early Tender Deadline” and the “Expiration Date” for each Exchange
Offer as described below. Other than as described herein, all other
terms, conditions and applicable dates of the Exchange Offers remain
unchanged.
The Issuer was advised by the exchange agent for the Exchange Offers
that, as of 5:00 p.m., New York City time, on June 5, 2018, a total of
(i) $1,547,516,000 aggregate principal amount of outstanding 2019 Notes,
representing approximately 80% of the outstanding 2019 Notes, (ii)
$960,183,000 aggregate principal amount of outstanding 2020 Notes,
representing approximately 80% of the outstanding 2020 Notes, and (iii)
$2,829,013,000 aggregate principal amount of outstanding 2022 Notes,
representing approximately 94% of the outstanding 2022 Notes, were
validly tendered (and not validly withdrawn) in the Exchange Offers.
Because the aggregate principal amount of Old Notes validly tendered as
of 5:00 p.m., New York City time, on June 5, 2018 would, if accepted for
exchange, cause the Maximum Exchange Amount to be exceeded, pursuant to
the terms of the Exchange Offer, tenders of 2022 Notes accepted for
exchange will be subject to proration.
The “Expiration Date” and the “Early Tender Deadline” for each Exchange
Offer has been extended from 5:00 p.m., New York City time, on Friday,
June 8, 2018 to midnight, New York City time, at the end of the day on
Tuesday, June 19, 2018. As a result, the deadline for tendering Old
Notes in order to receive the total consideration of (i) $1,000
principal amount of 2023 Notes (including the increased interest rate
described in this press release) per $1,000 principal amount of 2019
Notes tendered and accepted for exchange, (ii) $1,000 principal amount
of 2024 Notes per $1,000 principal amount of 2020 Notes tendered and
accepted for exchange and (iii) $750 principal amount of 2024 Notes per
$1,000 principal amount of 2022 Notes tendered and accepted for exchange
is now midnight, New York City time, at the end of the day on Tuesday,
June 19, 2018. The tender withdrawal deadline has passed. Accordingly,
tenders of Old Notes may no longer be withdrawn.
The Exchange Offers remain subject to the conditions set forth in the
Offering Memorandum, dated May 4, 2018 (the “Offering Memorandum”) and
related Letter of Transmittal, dated May 4, 2018 (the “Letter of
Transmittal”), including the condition that at least 90% of the
outstanding aggregate principal amount of the 2019 Notes are tendered in
the Exchange Offers (the “Minimum Tender Amount Condition”). As of 5:00
p.m., New York City time, on June 5, 2018, the Minimum Tender Amount
Condition has not been satisfied. The Issuer reserves the right, subject
to applicable law, to terminate, withdraw or amend each Exchange Offer
at any time and from time to time, as described in the Offering
Memorandum.
Pursuant to the terms of the exchange agreement between the Issuer and
certain institutional investors that are holders of Old Notes, any
amendment or waiver of the Minimum Tender Amount Condition requires
prior written consent of such holders and there can be no assurance such
amendment or waiver will be granted.
Each series of New Notes will be guaranteed by the Company and certain
of its existing and future domestic subsidiaries that guarantee the
Issuer’s outstanding senior secured credit facilities, ABL facility and
senior notes. In addition, each series of New Notes and related
guarantees will be secured by (i) second-priority liens on the
collateral that secures on a first-priority basis the Issuer’s
outstanding senior secured credit facilities (subject to certain
exceptions) and existing secured notes and (ii) third-priority liens on
the collateral that secures on a first-priority basis the Issuer’s
outstanding ABL facility, in each case subject to permitted liens
described in the Offering Memorandum.
The New Notes have not been registered under the Securities Act of 1933,
as amended (the “Securities Act”) or any state securities laws. The New
Notes may not be offered or sold in the United States or to any U.S.
persons except pursuant to an exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act. The
Exchange Offers are being made, and each series of New Notes are being
offered and issued only (i) in the United States to holders of Old Notes
who the Issuer reasonably believes are “qualified institutional buyers”
(as defined in Rule 144A under the Securities Act) and (ii) outside the
United States to holders of Old Notes who are (A) persons other than
U.S. persons, within the meaning of Regulation S under the Securities
Act, and (B) “non-U.S. qualified offerees” (as defined in the Offering
Memorandum).
The complete terms and conditions of the Exchange Offers are set forth
in the Offering Memorandum and related Letter of Transmittal. Copies of
the Offering Memorandum and Letter of Transmittal may be obtained from
Global Bondholder Services Corporation, the exchange agent and
information agent for the Exchange Offers, at (866) 470-3800 (toll free)
or (212) 430-3774 (collect).
This press release is for informational purposes only. This press
release is neither an offer to sell nor a solicitation of an offer to
buy any New Notes and is neither an offer to purchase nor a solicitation
of an offer to sell any Old Notes. The Exchange Offers are being made
only by, and pursuant to, the terms set forth in the Offering Memorandum
and the Letter of Transmittal. The Exchange Offers are not being made to
persons in any jurisdiction in which the making or acceptance thereof
would not be in compliance with the securities, blue sky or other laws
of such jurisdiction.
Forward-Looking Statement
This press release may include information that could constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements involve risk and
uncertainties.The Company undertakes no obligation to revise or
update any forward-looking statements, or to make any other
forward-looking statements, whether as a result of new information,
future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180606005437/en/
Source: Community Health Systems, Inc.
Community Health Systems, Inc.
Thomas J. Aaron, 615-465-7000
Executive
Vice President
and Chief Financial Officer
or
Ross W.
Comeaux, 615-465-7012
Vice President – Investor Relations